Volume 29, Number 9—September 2023
Research
Validation of Claims-Based Algorithm for Lyme Disease, Massachusetts, USA
Table 3
Numbers of reviewed charts and positive predictive values according to case definitions and other factors during January 2015–June 2019 in study of validation of claims-based algorithm for Lyme disease, Massachusetts, USA*
Factors | Reviewed charts | Confirmed | Probable | Suspected | Not LD | % PPV (95% CI)† | % PPV (95% CI)‡ |
---|---|---|---|---|---|---|---|
Overall |
128 |
70 |
15 |
35 |
8 |
93.8 (88.1–97.3) |
66.4 (57.5–74.5) |
Age group, y | |||||||
Pediatric, <18 | 25 (19.5%) | 19 | 3 | 3 | 0 | 100 (86.3–100) | 88 (68.8–97.5) |
Adults, >18 |
103 (80.5%) |
51 |
12 |
32 |
8 |
92.2 (85.3–96.6) |
61.2 (51.1–70.6) |
ICD era§ | |||||||
ICD-9-CM | 25 (19.5%) | 16 | 3 | 4 | 2 | 92.0 (74.0–99.0) | 76.0 (54.9–90.6) |
ICD-10-CM |
103 (80.5%) |
54 |
12 |
31 |
6 |
94.2 (87.8–97.8) |
64.1 (54.0–73.3) |
Healthcare facility type | |||||||
Primary care | 95 (74.2%) | 51 | 14 | 26 | 4 | 95.8 (89.6–98.8) | 68.4 (58.1–77.6) |
Urgent care | 17 (13.3%) | 12 | 1 | 4 | 0 | 100 (80.5–100) | 76.5 (50.1–93.2) |
Other¶ |
16 (12.5%) |
7 |
0 |
5 |
4 |
75.0 (47.6–92.7) |
31.3 (11.0–58.7) |
Laboratory tests# | 68 (53.1%) | 27 | 15 | 21 | 5 | 92.7 (83.7–97.6) | 61.8 (49.2–73.3) |
*Values are no. (%) except as indicated. Lyme disease case definitions are confirmed, probable, suspected, and not Lyme disease. ICD, International Classification of Diseases; ICD-9, ICD, 9th Revision, Clinical Modification; ICD-10, ICD, 10th Revision, Clinical Modification; LD, Lyme disease; PPV, positive predictive value. †Confirmed, probable, or suspected cases. ‡Confirmed or probable cases only. §Case dates were January 2015–September 2015 for ICD-9 and October 2015–June 2019 for ICD-10. ¶Includes specialist practice (n = 5), emergency department (n = 3), telephone encounter (n = 3), and unknown facility type (n = 5). #Laboratory testing performed (regardless of result).